A previous study reported that among post-stroke patients, only 10.6%, 10.1%, 7.6%, 2.3%, 18.2%, and 1.4% were regularly taking antiplatelet drugs, β-blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium-channel blockers, and statins, respectively [19]. The gene discussed is ACE; the disease is stroke disorder.